The in vitro susceptibility of 27 Campylobacter jejuni, 31 Campylobacter coli, and 30 Campylobacter fetus subsp. fetus strains to 12 antimicrobial agents was determined. Ciprofloxacin, a new quinoline derivative, was the most active agent tested. Antimicrobial susceptibility differed among the three species tested.
Campylobacter fetus subsp. jejuni is recognized as a major worldwide cause of bacterial diarrhea. DNA homology studies have demonstrated that this trinomial actually represents two organisms, Campylobacter jejuni and Campylobacter coli (1) . C. jejuni, by far the more common isolate, typically produces a syndrome of diarrhea, fever, and crampy abdominal pain. Documented bacteremia due to C. jejuni is rare. C. coli accounts for fewer than 5% of human Campylobacter isolates from stool samples and produces a syndrome similar to that produced by C. jejuni (8) . Campylobacterfetus subsp. fetus (formerly Campylobacter fetus subsp. intestinalis) is a rare stool isolate. The most common syndrome due to this organism is bacteremia and fever in immunocompromised patients (2) .
There is little information on the antimicrobial susceptibilities of C. coli and C. fetus subsp. fetus compared with that of C. jejuni. Therefore, the activities of 12 antimicrobial agents, including two new agents, ciprofloxacin and ampicillin-sulbactam, were determined for 27 strains of C. jejuni, 31 strains of C. coli, and 30 strains of C. fetus subsp. fetus.
Hippurate testing by the method of Hwang and Ederer was used to separate C. jejuni and C. coli strains (4, 5) . Susceptibility testing was performed on Wilkins-Chalgren agar by standard agar dilution methods (7) . Inocula were prepared by transferring three to five colonies from a 24-h growth of each organism into Wilkins-Chalgren broth. The incubation temperature was 42°C for C. jejuni and C. coli and 35°C for C. fetus subsp. fetus strains. After 4 to 6 h of growth, the turbidity was adjusted to a 0.5 McFarland turbidity standard with sterile saline. Before inoculation, the organism suspension was diluted 1:10. Plates were inoculated with a multipoint replicator (Cathra, St. Paul, Minn.) designed to deliver exactly 0.001 ml per spot to the surface of antibiotic-impregnated agar. The inoculum contained approximately 104 CFU of bacteria per spot. Plates were inoculated from the lowest to the highest concentration of antibiotic to prevent any carry-over. All organisms were incubated in a microaerophilic atmosphere by the poly bag technique (6) . Plates were read at 24 and 48 h. A control plate without antibiotics was inoculated before and after each antibiotic series, and appropriate control organisms were included in each series of antibiotic plates. The MIC * Corresponding author.
was defined as the lowest concentration of antibiotic at which there was no visible growth after 48 h.
Most organisms were tested for the production of a beta-lactamase by using the cefinase disk method (BBL Microbiology Systems, Cockeysville, Md.) and following the recommended procedures of the manufacturer. Appropriate positive and negative controls were included.
Compounds used in this study were Thymidine phosphorylase (Burroughs Wellcome Co.), 0.1 U/ml of agar, was added to all plates when testing trimethoprim-sulfamethoxazole. Table 1 shows the comparative activity of 12 antimicrobial agents against C. jejuni, C. coli, and C. fetus subsp. fetus expressed as the MIC for 50 and 90% of the isolates (MIC50 and MIC90, respectively) and the MIC range for each antimicrobial agent. Ciprofloxacin, gentamicin, cefotaxime, and clindamycin all demonstrated good in vitro activity against all three Campylobacter spp. Ciprofloxacin, a new quinoline derivative structurally related to nalidixic acid, was the most active antibiotic tested for C. jejuni and C. coli, with an MIC90 of 0.125 ,ug/ml for both organisms. Although C. jejuni and C. coli have similar growth characteristics and clinically produce similar syndromes, these enteric Campylobacter spp. differed in their in vitro susceptibility to some antimicrobial agents. Trimethoprim-sulfamethoxazole was more active against C. jejuni (MIC90 = 2 ,ug/ml) than against C. coli (MIC90 = 8 ,ug/ml). More importantly, -erythromycin, the agent of choice for serious infections due to C. jejuni (MIC90 = 2 ,ug/ml), was much less active against strains of C. coli (MIC90 > 32 ,g/ml). Of interest, both C. jejuni and C. coli showed similar susceptibility to doxycycline, with organisms being either very susceptible or highly resistant.
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High-level tetracycline resistance has been d be plasmid mediated for C. jejuni (9) . Tran plasmid from C. jejuni to C. fetus subsp. demonstrated (9). Presumably, high-level teti ance in C. coli is also plasmid mediated.
As expected, nalidixic acid was less active subsp. fetus (MIC90 > 128 ,ug/ml) than a (MIC90 = 8 ,ug/ml). This difference in s nalidixic acid, as detected by a 30-,ug disk, h separate these species. High-level resistance was not seen among the strains of C. fetus 4 tested. Finally, cephalothin was moderatel)
many strains of C. fetus subsp. fetus (MIC5 whereas nearly all C. coli and C. jejuni strains were resistvsmission of the ant. fetus has been When the cefinase disk method was used, 25 of 27 C. racycline resist-jejuni and 29 of 31 C. coli strains produced a beta-lactamase.
None of the C. fetus subsp. fetus strains produced a betaagainst C.fetus lactamase. The lack of activity of cephalothin suggests that it gainst C. jejuni is a cephalosporinase. This is supported by the excellent usceptibility to activity of cefotaxime, a beta-lactamase-stable cephalospoas been used to rin. The unexpectedly higher activity of ampicillin, as demto doxycycline onstrated by agar plate dilution testing, may be due to the subsp. fetus we small number (104) of organisms used as the inoculum (an y active against inoculum effect) or may reflect a lack of activity of the 50 = 16 ,ug/ ml), beta-lactamase against ampicillin. The latter proposal is supported by the failure of sulbactam to enhance the activity of ampicillin.
Our study demonstrates that, whereas C.jejuni and C. 
